An overview of research into ankylosing spondylitis and rheumatoid arthritis

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade.

Annals of the rheumatic diseases·2008

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.

Arthritis and rheumatism·2006

Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis.

Arthritis and rheumatism·2005

Anti-TNF therapy: where have we got to in 2005?

Journal of autoimmunity·2005

The 2005 International Symposium on Advances in Targeted Therapies: what have we learned in the 2000s and where are we going?

Annals of the rheumatic diseases·2005

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.

Arthritis and rheumatism·2005

Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection.

British journal of rheumatology·1999

Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients.

British journal of rheumatology·1999

Circulating interleukin-16 in systemic lupus erythematosus.

British journal of rheumatology·1999

Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis.

British journal of rheumatology·1999

Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years.

British journal of rheumatology·1999

A study of the frequency of pericardial and pleural effusions in scleroderma.

British journal of rheumatology·1999

A retrospective evaluation of antibiotic prescribing for recurrent urinary tract infection prophylaxis in adults in general practice.

Family practice·2026

Combined detection of HLA-B27, ESR, and CRP as biochemical and immunogenetic markers in the auxiliary diagnosis of ankylosing spondylitis.

Journal of medical biochemistry·2026

Biomarkers in axial spondyloarthritis diagnosis: from clinical signs to multi-omics integration.

Frontiers in immunology·2026

Real-world drug survival and treatment outcome of ixekizumab in patients with spondyloarthropathies.

Frontiers in immunology·2026

A case report of sporadic Creutzfeldt-Jakob disease presenting with progressive opsoclonus-myoclonus-ataxia-Plus (OMAS-Plus) phenotype.

Prion·2026

Time to redefine serum uric acid levels in women: A call for sex-specific cardiometabolic risk thresholds.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026

Related Experiment Videos

An overview of research into ankylosing spondylitis and rheumatoid arthritis

Related Concept Videos

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade.

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.

Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis.

Anti-TNF therapy: where have we got to in 2005?

The 2005 International Symposium on Advances in Targeted Therapies: what have we learned in the 2000s and where are we going?

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.

Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection.

Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients.

Circulating interleukin-16 in systemic lupus erythematosus.

Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis.

Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years.

A study of the frequency of pericardial and pleural effusions in scleroderma.

A retrospective evaluation of antibiotic prescribing for recurrent urinary tract infection prophylaxis in adults in general practice.

Combined detection of HLA-B27, ESR, and CRP as biochemical and immunogenetic markers in the auxiliary diagnosis of ankylosing spondylitis.

Biomarkers in axial spondyloarthritis diagnosis: from clinical signs to multi-omics integration.

Real-world drug survival and treatment outcome of ixekizumab in patients with spondyloarthropathies.

A case report of sporadic Creutzfeldt-Jakob disease presenting with progressive opsoclonus-myoclonus-ataxia-Plus (OMAS-Plus) phenotype.

Time to redefine serum uric acid levels in women: A call for sex-specific cardiometabolic risk thresholds.

Related Experiment Videos

An overview of research into ankylosing spondylitis and rheumatoid arthritis

Related Concept Videos

Related Articles